Medical Weight Loss for Rutland, Vermont Residents

Rutland, Vermont residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Rutland through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Rutland: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps Vermont patients choose. Doctor review just $119 (medication separate).

Why Rutland Residents Choose New Hope Weight Loss

Continuity is the quiet advantage Rutland patients notice most. Because Dr. Anjmun Sharma oversees your case throughout, the person adjusting your dose in month three is the same physician who reviewed you in week one. Nothing gets lost in a handoff. That consistency, delivered by telehealth from our Costa Mesa clinic, is what turns a prescription into actual ongoing care for people all over Vermont.

Rutland residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Rutland address.

There is no New Hope Weight Loss office in Rutland, and there does not need to be, since the same doctor-led program is delivered to every corner of Vermont through telehealth visits. We care for patients throughout Downtown and the greater Rutland County area. From your first question to your ongoing refills, the whole Vermont experience is built to feel personal, private, and genuinely supported.

Distance simply stops mattering here, since every appointment for Rutland residents takes place over secure video rather than in a waiting room. Cold-pack shipping to Rutland is handled for you, and refills are coordinated through telehealth so you do not have to manage a pharmacy pickup. Even in the rural reaches of Vermont, New Hope Weight Loss reaches patients by secure telehealth from our Costa Mesa, California clinic, so distance never limits your physician-supervised care.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Rutland telehealth patients.

How Telehealth Works for Rutland

Here is what to expect, step by step, from anywhere in Rutland.

Step 1. Fill out a quick intake quiz about your weight, health history, and goals.

Step 2. Dr. Anjmun Sharma reviews your intake and meets you by secure video, usually within 48 hours, to decide whether compounded semaglutide or tirzepatide is right for you.

Step 3. If she prescribes, a state-licensed 503(a) pharmacy ships your medication to your Rutland address in cold-pack packaging.

Step 4. You keep going with video follow-ups, no office visit required, anywhere in .

Frequently Asked Questions, Rutland

Can people from Rutland get treated by New Hope Weight Loss?

Absolutely. We operate one physical clinic in Costa Mesa, California, and we provide telehealth care to Rutland, Vermont. Whether you are in Downtown and the greater Rutland County area or elsewhere in the area, the path is the same. Dr. Anjmun Sharma meets you by video and confirms if a compounded GLP-1 program is right for you.

Do Rutland patients ever have to come into the office?

Never. Care is delivered entirely through telehealth, which means Rutland residents stay home for consults, follow-ups, and questions. Once Dr. Sharma approves you, your compounded semaglutide or tirzepatide is mailed to Rutland inside cold-pack packaging that holds the right temperature in transit.

What is the cost breakdown for Rutland?

You pay $119 for the physician review. Semaglutide begins at $166 a month, or $499 across 90 days, and tirzepatide begins at $233 a month. Medication is a separate charge. We accept HSA, FSA, Klarna, and Affirm payments, and there is no distance surcharge applied to anyone in Rutland.

What areas of Rutland do you serve?

We serve patients from across Rutland by telehealth, including Downtown and the greater Rutland County area.

What makes this different from a local Rutland medspa or clinic?

A named, licensed physician, Dr. Anjmun Sharma, supervises every case. Contraindications are screened at intake, the 503(a) compounding pharmacy is identified, and pricing is flat and stated up front. Rutland patients get a real physician-led medical practice by telehealth, not a quick membership sign-up.

Rutland Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Rutland, Vermont by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.